GH
Gregor Hutter
University of Basel: Universitat Basel, University of Zurich
Research areas: Medicine · Oncology · Glioma Diagnosis and Treatment · Cancer Immunotherapy and Biomarkers · Neuroinflammation and Neurodegeneration Mechanisms
0000-0002-7570-3902
Employment
-
University of Basel: Universitat Basel
Education
- 2004 - 2008
- 1998 - 2004
Projects & Funding
-
Phosphoproteomic Profiling of Glioma Stem Cells Universität Basel2009 - 2010
-
Charakterisierung der Immunpathogenese von Prionenerkrankungen mittels Rekonstitution eines menschlichen Immunsystems in Mäusen.Beitrag im Rahmen des MD-PhD-Programmes. Swiss National Science Foundation2004 - 2007
-
Charakterisierung der Immunpathogenese von Prionenerkrankungen mittels Rekonstitution eines menschlichen Immunsystems in Mäusen.Beitrag im Rahmen des MD-PhD-Programmes. Swiss National Science Foundation2004 - 2007
Publications (137)
- Recent Locoregional CAR T-Cell Trials for the Treatment of Recurrent Glioblastoma: Implications for Neuro-Oncology Practice Save
- The brain-meningeal interface functions as a reservoir and entry site for brain parenchymal macrophages Save
- Progressive neuronal network reorganisation in glioblastoma drives pathological activity in vitro Save
- Increase of Inhibitory Siglec receptors on T cells mitigates severe immune reactions during acute viral infections Save
- In vivo screening of TCR-based chimeric antigen receptors for improved anti-tumor functionality Save
- Adoptive cell therapy with macrophage-drug conjugates facilitates cytotoxic drug transfer and immune activation in glioblastoma models Save
- Quantitative Proteomic Analysis Reveals Different Functional Subtypes among IDH-Wildtype Glioblastoma. Save
- FcRn-silencing of IL-12Fc prevents toxicity of local IL-12 therapy and prolongs survival in experimental glioblastoma. Save
- Bifunctional Phagocytic Synapse Enhancers for Cancer Immunotherapy Save
- Quantitative proteomic analysis reveals different functional subtypes among IDH-wildtype glioblastoma Save
- Multidimensional analysis of matched primary and recurrent glioblastoma identifies contributors to tumor recurrence influencing time to relapse. Save
- Patient-Derived Glioblastoma Explants Empower Rapid and Personalized Drug Assessment: Harnessing the Potential of 3D Perfusion Bioreactors in Glioblastoma Drug Discovery. Save
- Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ-derived CD47 blocker. Save
- Rapid brain lymphoma diagnostics through nanopore sequencing of cytology-negative cerebrospinal fluid. Save
- Leveraging multi-omics data to infer regulators of mRNA 3' end processing in glioblastoma. Save
- Editorial: The therapeutic inhibition of macrophage checkpoints. Save
- Quantitative Proteomic Analysis Reveals Different Functional Subtypes Among IDH-Wildtype Glioblastoma Save
- Quantitative Proteomic Analysis Reveals Different Functional Subtypes Among Idh-Wildtype Glioblastoma Save
- SPATIALLY RESOLVED FUNCTIONAL PROFILING FOR GLIOBLASTOMA Save
- Single-cell characterization of human GBM reveals regional differences in tumor-infiltrating leukocyte activation Save